CVS Health Stock Price, News & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 10th. Stockholders of record on Thursday, July 25th will be given a dividend of $0.50 per share on Friday, August 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Wednesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Wednesday, August, 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.19. The pharmacy operator earned $63.43 billion during the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. CVS Health's revenue for the quarter was up 35.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.69 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus estimate of $6.84.

27 Wall Street analysts have issued 1 year price objectives for CVS Health's shares. Their forecasts range from $61.00 to $100.00. On average, they expect CVS Health's share price to reach $75.9130 in the next twelve months. This suggests a possible upside of 18.1% from the stock's current price. View Analyst Price Targets for CVS Health.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media headlines about CVS stock have trended negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CVS Health earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave news stories about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), Johnson & Johnson (JNJ), NVIDIA (NVDA), Alibaba Group (BABA), Verizon Communications (VZ), Intel (INTC), Home Depot (HD) and Bank of America (BAC).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.87%), Price T Rowe Associates Inc. MD (1.43%), Northern Trust Corp (1.41%), Barrow Hanley Mewhinney & Strauss LLC (1.31%), Morgan Stanley (1.06%) and Bank of New York Mellon Corp (1.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Parnassus Investments CA, CIBC Private Wealth Group LLC, Boston Partners, Prudential Financial Inc., UBS Asset Management Americas Inc., Bank of New York Mellon Corp and Pictet Asset Management Ltd.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Morgan Stanley, Prudential PLC, Vanguard Group Inc., Parametric Portfolio Associates LLC, Poplar Forest Capital LLC, Invesco Ltd. and LSV Asset Management. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $64.30.

CVS Health has a market capitalization of $83.62 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]